Meeting
2023 ASCO Gastrointestinal Cancers Symposium
A multicenter, phase 1 study of AB011, a recombinant humanized anti-CLDN18.2 monoclonal antibody, as monotherapy and combined with capecitabine and oxaliplatin (CAPOX) in patients with advanced solid tumors.
Authors
Jin Li
Tongji University Shanghai East Hospital, Shanghai, China;
Jin Li , Hongming Pan , Tianshu Liu , Nong Xu , Yanqiao Zhang , Yanru Qin , Jianhua Shi , Dongcheng Liao , Lin Shen , Suxia Luo , Yueyin Pan , Wei Zhao , Yu Zheng , Rongyuan Zhuang , Chenyu Mao , Yue Ma , Huamao Wang , Zonghai Li
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT04400383
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 391)
DOI
10.1200/JCO.2023.41.4_suppl.391
Abstract #
391
Poster Bd #
G13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Safety and preliminary efficacy of MIL93 in patients with advanced solid tumors: The monotherapy part of a phase 1 trial.
First Author: Jing Huang
Poster
2022 ASCO Annual Meeting
A phase I study of TST001, a high affinity humanized anti-CLDN18.2 monoclonal antibody, in combination with capecitabine and oxaliplatin (CAPOX) as a first-line treatment of advanced G/GEJ cancer.
First Author: Jifang Gong
Poster
2012 Gastrointestinal Cancers Symposium
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
First Author: Fatima A. Rangwala
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Efficacy and safety of nivolumab and CapeOX in patients with previously untreated FGFR2-positive, PD-L1-positive advanced gastric cancer: A single-arm, multicenter, phase 2 study NIVOFGFR2.
First Author: Ilya Tsimafeyeu